Clinical trial

BIBW2992 (Afatinib) in Advanced (EGFR-FISH +) NSCLC (Non Small Cell Lung Cancer) Patients

NCT00796549

Study summary

ClinicalTrials.gov

BIBW2992 (Afatinib) in Advanced (EGFR-FISH +) NSCLC (Non Small Cell Lung Cancer) Patients

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention BiBW 2992 Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-12-01

PhasePHASE2

Conditions

Carcinoma, Non-Small-Cell Lungunresolved

Interventions

BiBW 2992DRUG

Sponsors & collaborators

Boehringer Ingelheimlead sponsor

Mapped research locations

GenovaItaly1 PadovaItaly1 ModenaItaly1 PerugiaItaly1 RavennaItaly1 LivornoItaly1 PratoItaly1 ArezzoItaly1 Rozzano (MI)Italy1 Aviano (PN)Italy1 Lugo (RA)Italy1 Faenza (RA)Italy1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00796549 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.